Halozyme has completed its acquistion of Antares Pharma, creating a leading drug delivery business. View details here.
For InvestorsAntares Pharma: Making Medicines Feel Better

SEC Filings

Search By Keyword:
Filter By Year:
Filter By Type:
Showing 151 to 200 of 619
Date Title Type
2018-02-16SC 13G - Statement of acquisition of beneficial oSC 13G
2018-02-14SC 13G/A [Amend] - Statement of acquisition of beSC 13G/A
2018-02-13SC 13G/A [Amend] - Statement of acquisition of beSC 13G/A
2018-02-01SC 13G - Statement of acquisition of beneficial oSC 13G
2017-11-0710-Q - Quarterly report [Sections 13 or 15(d)]10-Q
2017-11-078-K - Current report8-K
2017-10-208-K - Current report8-K
2017-10-128-K - Current report8-K
2017-10-108-K - Current report8-K
2017-08-118-K - Current report8-K
2017-08-11424B5 - Prospectus [Rule 424(b)(5)]424B5
2017-08-098-K - Current report8-K
2017-08-0810-Q - Quarterly report [Sections 13 or 15(d)]10-Q
2017-08-088-K - Current report8-K
2017-06-098-K - Current report8-K
2017-06-088-K - Current report8-K
2017-06-078-K - Current report8-K
2017-05-19EFFECT - Notice of EffectivenessEFFECT
2017-05-16CORRESP [Cover] - CorrespondenceCORRESP
2017-05-12UPLOAD [Cover] - SEC-generated letterUPLOAD
2017-05-09S-3 - Registration statement under Securities ActS-3
2017-05-0910-Q - Quarterly report [Sections 13 or 15(d)]10-Q
2017-05-098-K - Current report8-K
2017-04-27DEF 14A - Other definitive proxy statementsDEF 14A
2017-03-1410-K - Annual report [Section 13 and 15(d), not S10-K
2017-03-148-K - Current report8-K
2017-03-068-K - Current report8-K
2017-02-14SC 13G/A [Amend] - Statement of acquisition of beSC 13G/A
2017-02-13SC 13G/A [Amend] - Statement of acquisition of beSC 13G/A
2017-01-278-K - Current report8-K
2016-11-0910-Q - Quarterly report [Sections 13 or 15(d)]10-Q
2016-11-098-K - Current report8-K
2016-11-018-K - Current report8-K
2016-09-278-K - Current report8-K
2016-09-148-K - Current report8-K
2016-09-078-K - Current report8-K
2016-08-118-K - Current report8-K
2016-08-0910-Q - Quarterly report [Sections 13 or 15(d)]10-Q
2016-08-098-K - Current report8-K
2016-07-08SC 13G/A [Amend] - Statement of acquisition of beSC 13G/A
2016-07-018-K - Current report8-K
2016-06-168-K - Current report8-K
2016-06-088-K - Current report8-K
2016-06-078-K - Current report8-K
2016-06-06CT ORDER - Confidential treatment orderCT ORDER
2016-06-06CT ORDER - Confidential treatment orderCT ORDER
2016-06-02S-8 - Securities to be offered to employees in emS-8
2016-05-0910-Q - Quarterly report [Sections 13 or 15(d)]10-Q
2016-05-098-K - Current report8-K
2016-04-22DEF 14A - Other definitive proxy statementsDEF 14A
Showing 151 to 200 of 619